taufab

Tomohiro Tsuchida1, Takahiro Tsuchiya2, Katsuhiko Minoura2

  • 1Faculty of Pharmaceutical Sciences, Osaka Medical and Pharmaceutical University, 4-20-1, Nasahara, Takatsuki, Osaka 569-1094, Japan; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1, Niijuku, Katsushika-ku, Tokyo 125-8585, Japan.

PubMed
概括

研究人员研究了抗体片段 (Fab2r3) 如何选择性地与阿尔茨海默病病理学中至关重要的VQIINK结合. 他们发现,中的Ile-4和Fab2r3中的特定口袋是这种选择性抑制的关键.